Arrowhead Pharmaceuticals Inc (ARWR)

Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell

$14.83

Buy

$15.50

arrow-up$0.43 (+2.88%)

Prices updated at 15 May 2025, 13:00 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Arrowhead Pharmaceuticals Inc is a biotechnology company. It is engaged in the development of medicine to treat diseases such as hepatitis B, and thrombosis with a genetic origin, primarily divided by the overproduction of one or more proteins.
NASDAQ
arrow-down-0.18%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Biotechnology
Chairman
Dr. Christopher Anzalone,PhD
CEO
Dr. Christopher Anzalone,PhD
Most recent earnings
30 Sep 2024
Fiscal year end
30 Sep 2024
Employees
609
Head office
177 E Colorado Boulevard
Pasadena
United States
91105
mobile
+1 626 304-3400
letter
ir@arrowheadpharma.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Mr. Douglas S. Ingram,Esq.
Independent Director
-
Dr. Douglass Given, PhD
Chairman of the Board
0.10m
Mr. Daniel Apel
Chief Financial Officer
-
Dr. Michael S. Perry, PhD
Independent Director
0.08m
Dr. Christopher Anzalone,PhD
Chairman of the Board, Chief Executive Officer and President
0.95m
Mr. James Hamilton
Chief of Discovery and Translational Medicine
0.57m
Dr. Mauro Ferrari, PhD
Independent Director
0.08m
Dr. Adeoye Olukotun, M.D.,M.P.H.
Independent Director
0.08m
Mr. William D. Waddill
Lead Independent Director
0.09m
Mr. Patrick C. O'Brien
Chief Operating Officer, General Counsel and Corporate Secretary
0.61m
Dr. Hongbo Lu, PhD
Independent Director
0.04m
Ms. Victoria Vakiener
Independent Director
0.08m

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
BlackRock Inc19,926,154
BlackRock Fund Advisors13,861,532
Vanguard Group Inc13,202,562
venBio Select Advisor LLC11,111,111
Avoro Capital Advisors LLC8,888,888

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
27 Dec 2024-
23 Dec 2024-
18 Dec 2024-
18 Dec 2024-
18 Dec 2024-
18 Dec 2024-
18 Dec 2024-
18 Dec 2024-
18 Dec 2024-
18 Dec 2024-
18 Dec 2024-
18 Dec 2024-
16 Dec 2024-
17 Dec 2024-
17 Dec 2024-
16 Dec 2024-
16 Dec 2024-
22 Mar 2024-
25 Sep 2024-
18 Apr 2024-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.